NECTIN2 and neoplasm: Research on CRC models has indicated that inhibition of the PVRIG-PVRL2 signaling pathway not only significantly reverses NK cell functional exhaustion but also effectively suppresses tumor progression in the MC38 colon cancer mouse model.